SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-16-006395
Accepted
2016-12-08 00:15:10
Documents
1
Effectiveness Date
2016-12-07
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-16-006395.txt   1744
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-214418 | Film No.: 162040289
SIC: 2834 Pharmaceutical Preparations